Abstract
The effect of oral calcium carbonate on serum lipoprotein concentrations was tested in 50 children with familial hypercholesterolemia (type II-A) consuming a low cholesterol high polyunsaturated fat diet, using a cross-over design versus a placebo. Cholesterol was measured in serum and in the individual lipoprotein density classes. Serum apolipoprotein B (the protein moiety of low density lipoprotein) and apolipoprotein A-I (the main protein of high density lipoprotein) were measured by specific immunoassays. Calcium carbonate treatment induced only a slight increase in serum apolipoprotein A-I (+4%) and a slight decrease in low density lipoprotein cholesterol (-4%), both changes being significant at the P=0.05 level.
Similar content being viewed by others
References
Albrink MJ, Meigs JW, Man EB (1961) Serum lipids, hypertension and coronary artery disease. Am J Med 13:4–23
Bhattacharyya AK, Thera C, Anderson JT, Grande F, Keys A (1969) Dietary calcium and fat: Effects on serum lipids and fecal excretion of cholesterol and its degradation products in man. Am J Clin Nutr 22:1161–1174
Bierenbaum ML, Fleischman AI, Raichelson RI (1972) Long term human studies on the lipid effects of oral calcium. Lipids 7:202–206
Boehringer, Produktprofile Monotest cholesterol CHODPAP method, Mannheim, GFR
Carlson LA, Böttiger LE (1972) Ischemic heart disease in relation to fasting values of plasma triglycerides and cholesterol. Lancet I:865–868
Carlson LA, Olsson AG, Orö L, Rössner S (1971) Effects of oral calcium upon serum cholesterol and triglycerides in patients with hyperlipidemia. Atherosclerosis 14:391–400
Drenick EJ (1961) The influence of ingestion of calcium and other soap-forming substances on fecal fat. Gastroenterology 41:242–244
Fernandes J, Dijkhuis-Stoffelsma R, Grose W (1977) Hypercholesterolemic children (type II-A) treated with high-linoleic acid diet and cholestyramine: the effect on serum lipids and platelet aggregation. Acta Paediatr Scand 66:621–624
Fredrickson DS, Goldstein JL, Brown MS (1978) The familial hyperlipoproteinemias. In: Stanbury JB, Wijngaarden JB Fredrickson DS (eds) The Metabolic Basis of Inherited Disease. McGraw-Hill, New York, pp 605–655
Glueck CJ, Fallet R, Tsang R (1973) Pediatric familial type-II hypercholesterolemia—Therapy with diet and cholestyramine resin. Pediatrics 52:669–679
Gofman JW, Young W, Tandy R (1966) Ischemic heart disease, atherosclerosis and longlivity. Circulation 34:679–697
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawler TR (1977) High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62:707–714
Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 32:1345–1353
Horan JM, Di Luzio NR, Etteldorf JM (1964) Use of an anion exchange resin in treatment of two siblings with familial hypercholesterolemia. J Pediatr 64:201–209
Kannel WB, Castelli WP, Gordon T, et al. (1971) Serum cholesterol lipoproteins, and risk of coronary heart diseases. The Framingham study. Ann Intern Med 24:1–12
Koskinen P, Inkovaara J, Ala-Kaila K, Salo M, Nikkari T (1977) Effect of calcium p-chlorphenoxy isobutyrate and calcium carbonate on plasma lipids and lipopoteins of patients with hyperlipoproteinemia. Ann Clin Res 9:335–341
Laurell CB (1972) Electroimmunoassay. Scand J Clin Lab Invest 29 [Suppl] 124:21–37
Lees RS, Wilson DE (1971) The treatment of hyperlipidemia N Engl J Med 284:186–195
Maibach E (1967) Die Beeinflussung des Gesamtcholesterins, der β-Lipoproteide und Gesamtlipide des Serums durch orale und parenterale Calciumzufuhr. Schweiz Med Wochenschr 97:418–421
Maibach E (1968) deÜber die Beeinflussung des Gesamtcholesterins und der Gesamtlipide im Serum des Menschen durch orale Kalziumzufuhr. Wien Med Wochenschr 118:1059–1062
Miettinen M, Turpeinen O, Darvonen MJ, Elosno R, Paavilamien E (1972) Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. Lancet II: 835–838
Miller GJ, Miller NE (1975) Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet I:16–19
Redgrave TG, Roberts DCK, West CE (1975) Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem 65:42–49
Slack J (1969) Risks of ischaemic heart disease in familial hyperlipoproteinemic states. Lancet II:1380–1382
Wells WW, Cooper SB (1958) Coprostenol formation II. The opposing action of dietary lactose and calcium on cholesterol absorption. Arch Biochem Biophys 75:273–285
West RJ, Lloyd JK (1973) Use of cholestyramine in treatment of children with familial hypercholesterolemia. Arch Dis Childh 48:370–374
Yacowitz H, Fleischman AI, Bierenbaum ML (1965) Effects of oral calcium upon serum lipids in man. Br Med J I: 1352–1354
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Groot, P.H.E., Grose, W.F.A., Dijkhuis-Stoffelsma, R. et al. The effect of oral calcium carbonate administration on serum lipoproteins of children with familial hypercholesterolaemia (type II-A). Eur J Pediatr 135, 81–84 (1980). https://doi.org/10.1007/BF00445899
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00445899